MDXGNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
MIMEDX GROUP, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 29, 2026
$4.38−0.05 (-1.13%)
Close on Oct 19, 2026
- Market cap
- $647.35M
- P/E (TTM)
- 109.5
- Dividend yield
- –
MIMEDX GROUP, INC. revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Regenerative Medicine | – | – | – | – | – | – | – | – | – | – | – | $0 | – | – |
| Wound & Surgical | – | – | – | – | – | – | – | – | – | – | – | $305.08M | – | – |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Wound | $203.46M | $242.87M | $276.33M | $259.00M | $236.96M | $230.03M | $231.00M | $225.63M | $221.73M | $217.50M | $205.66M | – | 57.3% | -14.1% |
| Surgical | $151.71M | $146.55M | $142.30M | $134.44M | $126.82M | $122.35M | $117.88M | $117.18M | $118.73M | $117.01M | $115.82M | – | 42.7% | +19.6% |
| Section 351 | – | – | – | – | – | – | – | – | – | – | – | $895.00K | – | – |
| Tissue/Other | – | – | – | – | – | – | – | – | – | – | – | $284.57M | – | – |
| Cord | – | – | – | – | – | – | – | – | – | – | – | $23.30M | – | – |
| Hospital | – | – | – | – | – | – | $187.44M | $188.07M | $189.38M | $188.59M | $187.00M | $183.23M | – | – |
| Private Office | – | – | – | – | – | – | $112.39M | $110.47M | $107.84M | $104.63M | $95.79M | $90.58M | – | – |
| Other | – | – | – | – | – | – | $49.05M | $44.27M | $43.24M | $41.29M | $38.69M | $35.21M | – | – |
By region
From the segment and revenue-disaggregation notes of Mimedx's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.